185 related articles for article (PubMed ID: 23516425)
1. Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles.
Shi G; Cui W; Benchimol M; Liu YT; Mattrey RF; Mukthavaram R; Kesari S; Esener SC; Simberg D
PLoS One; 2013; 8(3):e58017. PubMed ID: 23516425
[TBL] [Abstract][Full Text] [Related]
2. Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles.
Shi G; Cui W; Mukthavaram R; Liu YT; Simberg D
Methods; 2013 Dec; 64(2):102-7. PubMed ID: 23974072
[TBL] [Abstract][Full Text] [Related]
3. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
[TBL] [Abstract][Full Text] [Related]
4. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
5. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
6. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
7. Vertical Magnetic Separation of Circulating Tumor Cells for Somatic Genomic-Alteration Analysis in Lung Cancer Patients.
Yoo CE; Park JM; Moon HS; Joung JG; Son DS; Jeon HJ; Kim YJ; Han KY; Sun JM; Park K; Park D; Park WY
Sci Rep; 2016 Nov; 6():37392. PubMed ID: 27892470
[TBL] [Abstract][Full Text] [Related]
8. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
9. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
Johnson ES; Anand RK; Chiu DT
Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
[TBL] [Abstract][Full Text] [Related]
10. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
[TBL] [Abstract][Full Text] [Related]
11. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
Magbanua MJ; Park JW
Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.
Weissenstein U; Schumann A; Reif M; Link S; Toffol-Schmidt UD; Heusser P
BMC Cancer; 2012 May; 12():206. PubMed ID: 22646670
[TBL] [Abstract][Full Text] [Related]
13. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
14. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.
Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH
ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).
Myung JH; Launiere CA; Eddington DT; Hong S
Langmuir; 2010 Jun; 26(11):8589-96. PubMed ID: 20155985
[TBL] [Abstract][Full Text] [Related]
16. Cancer-leukocyte hybrid membrane-cloaked magnetic beads for the ultrasensitive isolation, purification, and non-destructive release of circulating tumor cells.
Chang ZM; Zhang R; Yang C; Shao D; Tang Y; Dong WF; Wang Z
Nanoscale; 2020 Oct; 12(37):19121-19128. PubMed ID: 32929419
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.
Antolovic D; Galindo L; Carstens A; Rahbari N; Büchler MW; Weitz J; Koch M
BMC Biotechnol; 2010 Apr; 10():35. PubMed ID: 20426872
[TBL] [Abstract][Full Text] [Related]
18. Efficient capture and simple quantification of circulating tumor cells using quantum dots and magnetic beads.
Min H; Jo SM; Kim HS
Small; 2015 Jun; 11(21):2536-42. PubMed ID: 25630488
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
Kim MJ; Choi NY; Lee EK; Kang MS
Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871
[TBL] [Abstract][Full Text] [Related]
20. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]